161 related articles for article (PubMed ID: 12298113)
1. Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients.
Ollendorf DA; Vera-Llonch M; Oster G
Am J Health Syst Pharm; 2002 Sep; 59(18):1750-4. PubMed ID: 12298113
[TBL] [Abstract][Full Text] [Related]
2. Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery.
Baser O; Supina D; Sengupta N; Wang L; Kwong L
Am J Health Syst Pharm; 2010 Sep; 67(17):1438-45. PubMed ID: 20720243
[TBL] [Abstract][Full Text] [Related]
3. The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States.
Shahi A; Chen AF; Tan TL; Maltenfort MG; Kucukdurmaz F; Parvizi J
J Arthroplasty; 2017 Apr; 32(4):1063-1066. PubMed ID: 27866951
[TBL] [Abstract][Full Text] [Related]
4. Hospital charges associated with "never events": comparison of anterior cervical discectomy and fusion, posterior lumbar interbody fusion, and lumbar laminectomy to total joint arthroplasty.
Daniels AH; Kawaguchi S; Contag AG; Rastegar F; Waagmeester G; Anderson PA; Arthur M; Hart RA
J Neurosurg Spine; 2016 Aug; 25(2):165-9. PubMed ID: 26989978
[TBL] [Abstract][Full Text] [Related]
5. Inpatient resource use and cost burden of deep vein thrombosis and pulmonary embolism in the United States.
LaMori JC; Shoheiber O; Mody SH; Bookhart BK
Clin Ther; 2015 Jan; 37(1):62-70. PubMed ID: 25524389
[TBL] [Abstract][Full Text] [Related]
6. Effect of post-discharge venous thromboembolism on hospital quality comparisons following hip and knee arthroplasty.
Kester BS; Merkow RP; Ju MH; Peabody TD; Bentrem DJ; Ko CY; Bilimoria KY
J Bone Joint Surg Am; 2014 Sep; 96(17):1476-84. PubMed ID: 25187587
[TBL] [Abstract][Full Text] [Related]
7. Economic consequences of venous thromboembolism following major orthopedic surgery.
Oster G; Ollendorf DA; Vera-Llonch M; Hagiwara M; Berger A; Edelsberg J
Ann Pharmacother; 2004 Mar; 38(3):377-82. PubMed ID: 14742829
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.
Bullano MF; Willey V; Hauch O; Wygant G; Spyropoulos AC; Hoffman L
J Manag Care Pharm; 2005 Oct; 11(8):663-73. PubMed ID: 16194130
[TBL] [Abstract][Full Text] [Related]
9. A cost-analysis model for anticoagulant treatment in the hospital setting.
Mody SH; Huynh L; Zhuo DY; Tran KN; Lefebvre P; Bookhart B
J Med Econ; 2014 Jul; 17(7):492-8. PubMed ID: 24773068
[TBL] [Abstract][Full Text] [Related]
10. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations.
Spyropoulos AC; Lin J
J Manag Care Pharm; 2007; 13(6):475-86. PubMed ID: 17672809
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
Lu X; Lin J
BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review.
Januel JM; Chen G; Ruffieux C; Quan H; Douketis JD; Crowther MA; Colin C; Ghali WA; Burnand B;
JAMA; 2012 Jan; 307(3):294-303. PubMed ID: 22253396
[TBL] [Abstract][Full Text] [Related]
13. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
14. Venous Thromboembolism Rates Did Not Decrease in Lower Extremity Revision Total Joint Arthroplasty From 2008 to 2016.
Warren JA; Sundaram K; Kamath AF; Molloy RM; Krebs VE; Mont MA; Piuzzi NS
J Arthroplasty; 2019 Nov; 34(11):2774-2779. PubMed ID: 31153709
[TBL] [Abstract][Full Text] [Related]
15. Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in Belgium.
Annemans L; Minjoulat-Rey MC; De Knock M; Vranckx K; Czarka M; Gabriel S; Haentjens P
Acta Clin Belg; 2004; 59(6):346-57. PubMed ID: 15819379
[TBL] [Abstract][Full Text] [Related]
16. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.
Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S
J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169
[TBL] [Abstract][Full Text] [Related]
17. In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty.
Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
J Med Econ; 2012; 15(4):644-53. PubMed ID: 22356512
[TBL] [Abstract][Full Text] [Related]
18. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis.
Schiff RL; Kahn SR; Shrier I; Strulovitch C; Hammouda W; Cohen E; Zukor D
Chest; 2005 Nov; 128(5):3364-71. PubMed ID: 16304285
[TBL] [Abstract][Full Text] [Related]
19. The Incremental Cost of Inpatient Venous Thromboembolism After Hip Fracture Surgery.
Trivedi NN; Abola MV; Kim CY; Sivasundaram L; Smith EJ; Ochenjele G
J Orthop Trauma; 2020 Apr; 34(4):169-173. PubMed ID: 31977669
[TBL] [Abstract][Full Text] [Related]
20. Does thromboprophylaxis prevent venous thromboembolism after major orthopedic surgery?
Akpinar EE; Hoşgün D; Akan B; Ateş C; Gülhan M
J Bras Pneumol; 2013; 39(3):280-6. PubMed ID: 23857692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
